{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:37:50Z","timestamp":1777430270089,"version":"3.51.4"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT BACKGROUND: Proton pump inhibitors and histamine H2 receptor antagonists are two of the most commonly prescribed drug classes for pediatric gastroesophageal reflux disease, but their efficacy is controversial. Many patients are treated with these drugs for atypical manifestations attributed to gastroesophageal reflux, even that causal relation is not proven. OBJECTIVE: To evaluate the use of proton pump inhibitors and histamine H2 receptor antagonists in pediatric gastroesophageal reflux disease through a systematic review. METHODS: A systematic review was performed, using MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials databases. The search was limited to studies published in English, Portuguese or Spanish. There was no limitation regarding date of publication. Studies were considered eligible if they were randomized-controlled trials, evaluating proton pump inhibitors and\/or histamine H2 receptor antagonists for the treatment of pediatric gastroesophageal reflux disease. Studies published only as abstracts, studies evaluating only non-clinical outcomes and studies exclusively comparing different doses of the same drug were excluded. Data extraction was performed by independent investigators. The study protocol was registered at PROSPERO platform (CRD42016040156). RESULTS: After analyzing 735 retrieved references, 23 studies (1598 randomized patients) were included in the systematic review. Eight studies demonstrated that both proton pump inhibitors and histamine H2 receptor antagonists were effective against typical manifestations of gastroesophageal reflux disease, and that there was no evidence of benefit in combining the latter to the former or in routinely prescribing long-term maintenance treatments. Three studies evaluated the effect of treatments on children with asthma, and neither proton pump inhibitors nor histamine H2 receptor antagonists proved to be significantly better than placebo. One study compared different combinations of omeprazole, bethanechol and placebo for the treatment of children with cough, and there is no clear definition on the best strategy. Another study demonstrated that omeprazole performed better than ranitidine for the treatment of extraesophageal reflux manifestations. Ten studies failed to demonstrate significant benefits of proton pump inhibitors or histamine H2 receptor antagonists for the treatment of unspecific manifestations attributed to gastroesophageal reflux in infants. CONCLUSION: Proton pump inhibitors or histamine H2 receptor antagonists may be used to treat children with gastroesophageal reflux disease, but not to treat asthma or unspecific symptoms.<\/jats:p>","DOI":"10.1590\/s0004-2803.201700000-42","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T23:40:44Z","timestamp":1505950844000},"page":"271-280","source":"Crossref","is-referenced-by-count":15,"title":["ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW"],"prefix":"10.1590","volume":"54","author":[{"given":"\u00c2ngelo Zambam de","family":"MATTOS","sequence":"first","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre, Brazil; Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Brazil; Secretaria Municipal de Sa\u00fade de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Meirelles","family":"MARCHESE","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara Brum","family":"FONSECA","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"KUPSKI","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Brenner","family":"MACHADO","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"key":"ref1","first-page":"23","article-title":"A pilot trial on the treatment of gastroesophageal reflux-related cough in infants","volume":"1","author":"Adamko DJ","year":"2012","journal-title":"Transl Pediatr"},{"key":"ref2","first-page":"S43","article-title":"Sucralfate in the treatment of reflux esophagitis in children - preliminary results","volume":"156","author":"Arg\u00fcelles-Mart\u00edn F","year":"1989","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl","key":"ref3","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/0002-9343(89)90162-9","article-title":"Sucralfate versus Cimetidine in the Treatment of Reflux Esophagitis in Children","volume":"86","author":"Arg\u00fcelles-Martin F","year":"1989","journal-title":"Am J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins D","year":"2004","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3345\/kjp.2016.59.5.226","article-title":"Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants","volume":"59","author":"Azizollahi HR","year":"2016","journal-title":"Korean J Pediatr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1572-0241.2007.01152.x","article-title":"Maintenance Therapy for Erosive Esophagitis in Children After Healing by Omeprazole Is It Advisable?","volume":"102","author":"Boccia G","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref7","first-page":"304","article-title":"Efficacy of combined administration of an alginate formulation (\"gaviscon\") and lansoprazole for children with gastroesophageal reflux disease","volume":"28","author":"Borrelli O","year":"2002","journal-title":"Ital J Pediatr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1542\/peds.2005-1655","article-title":"Therapy With Gastric Acidity Inhibitors Increases the Risk of Acute Gastroenteritis and Community - Acquired Pneumonia in Children","volume":"117","author":"Canani RB","year":"2006","journal-title":"Pediatrics"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00005176-198902000-00005","article-title":"Cimetidine treatment of reflux esophagitis in children an Italian multicentric study","volume":"8","author":"Cucchiara S","year":"1989","journal-title":"J Ped Gastroenterol Nutr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/adc.69.6.655","article-title":"Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis","volume":"69","author":"Cucchiara S","year":"1993","journal-title":"Arch Dis Child"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/adc.59.9.842","article-title":"Antacids and cimetidine treatment for gastrooesophageal reflux and peptic oesophagitis","volume":"59","author":"Cucchiara S","year":"1984","journal-title":"Arch Dis Child"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpeds.2013.05.007","article-title":"Efficacy and Safety of Once-Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease in Neonatal Patients","volume":"163","author":"Davidson G","year":"2013","journal-title":"J Pediatr"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jpeds.2014.11.030","article-title":"No effect of proton pump inhibitors on crying and irritability in infants systematic review of randomized controlled trials","volume":"166","author":"Gieruszczak-Bialek D","year":"2015","journal-title":"J Pediatr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1183\/09031936.93.05020201","article-title":"A trial of ranitidine in asthmatic children and adolescents with or without pathological gastro-oesophageal reflux","volume":"5","author":"Gustafsson PM","year":"1992","journal-title":"Eur J Respir"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1080\/11024159850191175","article-title":"Gastro-Oesophageal Reflux Symptoms-Clinical Findings and Effect of Ranitidine Treatment","volume":"583","author":"Hallerb\u00e4ck B","year":"1998","journal-title":"Eur J Surg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jama.2011.2035","article-title":"Randomized Clinical Trial of Lansoprazole for Poorly Controlled Asthma in Children The American Lung Association Asthma Clinical Research Centers","volume":"307","author":"Holbrook JT","year":"2012","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MPG.0000000000000195","article-title":"Safety and Efficacy of Delayed Release Rabeprazole in 1- to 11-Month-Old Infants With Symptomatic GERD","volume":"58","author":"Hussain S","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1440-1754.2006.00786.x","article-title":"Effect of antireflux medication, placebo and infant mental health intervention on persistent crying A randomized clinical trial","volume":"42","author":"Jordan B","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions explanation and elaboration","volume":"339","author":"Liberati A","year":"2009","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MPG.0000000000000395","article-title":"Body Positioning and Medical Therapy for Infantile Gastroesophageal Reflux Symptoms","volume":"59","author":"Loots C","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/S0022-3476(03)00207-5","article-title":"Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux","volume":"143","author":"Moore DJ","year":"2003","journal-title":"J Pediatr"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.mpg.0000252190.97545.07","article-title":"Effect of Omeprazole on Acid Gastroesophageal Reflux and Gastric Acidity in Preterm Infants With Pathological Acid Reflux","volume":"44","author":"Omari TI","year":"2007","journal-title":"J Ped Gastroenterol Nutr"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-2036.2002.01243.x","article-title":"Ranitidine, 75 mg, over-the-counter dose pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux","volume":"16","author":"Orenstein SR","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jpeds.2008.09.054","article-title":"Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial Assessing the Efficacy and Safety of Proton Pump Inhibitor Lansoprazole in Infants with Symptoms of Gastroesophageal Reflux Disease","volume":"154","author":"Orenstein SR","year":"2009","journal-title":"J Pediatr"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1365-2036.2003.01559.x","article-title":"Famotidine for infant gastro-oesophageal reflux a multi-centre, randomized, placebo-controlled, withdrawal trial","volume":"17","author":"Orenstein SR","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.mpg.0000189354.48043.4e","article-title":"Nocturnal Acid Breakthrough in Children with Reflux Esophagitis Taking Proton Pump Inhibitors","volume":"42","author":"Pfefferkorn MD","year":"2006","journal-title":"J Ped Gastroenterol Nutr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00005176-199707000-00008","article-title":"Treatment of childhood peptic esophagitis a double-blind placebo-controlled trial of nizatidine","volume":"25","author":"Simeone D","year":"1997","journal-title":"J Ped Gastroenterol Nutr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/adc.2004.068890","article-title":"Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease","volume":"90","author":"Stordal K","year":"2005","journal-title":"Arch Dis Child"},{"key":"ref29","article-title":"Pharmacological treatment of children with gastrooesophageal reflux (Review)","author":"Tighe M","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1442-2050.2011.01301.x","article-title":"Impact of antisecretory treatment on respiratory symptoms of gastroesophageal reflux disease in children","volume":"25","author":"Ummarino D","year":"2012","journal-title":"Dis Esoph"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.2010-2719","article-title":"Efficacy of Proton-Pump Inhibitors in Children With Gastroesophageal Reflux Disease A Systematic Review","volume":"127","year":"2011","journal-title":"Pediatrics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/j.1536-4801.2012.tb00025.x","article-title":"Esomeprazole for the Treatment of GERD in Infants Ages 1-11 Months","volume":"55","author":"Winter H","year":"2012","journal-title":"J Ped Gastroenterol Nutr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MPG.0b013e3181c2bf41","article-title":"Efficacy and Safety of Pantoprazole Delayed-release Granules for Oral Suspension in a Placebo-controlled Treatment-withdrawal Study in Infants 1-11 Months Old With Symptomatic GERD","volume":"50","author":"Winter H","year":"2010","journal-title":"J Ped Gastroenterol Nutr"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v54n4\/1678-4219-ag-s0004280320170000042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T20:58:32Z","timestamp":1750885112000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032017000400271&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["S0004-28032017000400271"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.201700000-42","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,21]]}}}